Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine

01:02 EST 1 Jan 2014 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Vaxenta Biotechnologies announces the filing of a Patent Cooperation Treaty (PCT) application (SN: PCT/US13/55632) to the World Intellectual Property Organization (WIPO) covering a biological immunotherapeutic platform against c...

Other Sources for this Article

Vaxenta Biotechnologies
Boris Markosian, CEO, 818-823–3632
Fax: 858-227–9774
Email: bmarkosi@vaxenta.com

NEXT ARTICLE

More From BioPortfolio on "Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Searches Linking to this Story